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Abstract. 
 
To test the role of ER luminal environment 
in apoptosis, we generated HeLa cell lines inducible 
with respect to calreticulin and calnexin and investi-
gated their sensitivity to drug-dependent apoptosis. 
Overexpression of calreticulin, an ER luminal protein, 
resulted in an increased sensitivity of the cells to both 
thapsigargin- and staurosporine-induced apoptosis. 
This correlated with an increased release of cytochrome 
c from the mitochondria. Overexpression of calnexin, 
an integral ER membrane protein, had no signiﬁcant 
effect on drug-induced apoptosis. In contrast, calreticu-
lin-deﬁcient cells were signiﬁcantly resistant to apopto-
sis and this resistance correlated with a decreased re-
lease of cytochrome c from mitochondria and low levels 
of caspase 3 activity. This work indicates that changes in 
the lumen of the ER amplify the release of cytochrome 
c from mitochondria, and increase caspase activity, dur-
ing drug-induced apoptosis. There may be communica-
tion between the ER and mitochondria, which may in-
 
volve Ca
 
2
 
1
 
 and play an important role in conferring cell 
sensitivity to apoptosis. Apoptosis may depend on both 
the presence of external apoptosis-activating signals, 
and, as shown in this study, on an internal factor repre-
sented by the ER.
Key words: apoptosis • calreticulin • endoplasmic 
reticulum • calcium-binding protein
 
Introduction
 
The ER plays a critical role in a variety of process includ-
ing the maintenance of intracellular Ca
 
2
 
1
 
 homeostasis,
synthesis, posttranslational modification and folding of
membrane associated, secreted and integral membrane
proteins. In virtually all non-muscle cells, storage, release,
and uptake of Ca
 
2
 
1
 
 are regulated by proteins of the ER.
Ca
 
2
 
1
 
 in the lumen of the ER is either free or bound to lu-
minal proteins. It is released from the ER through the
inositol 1,4,5-trisphosphate (InsP
 
3
 
)
 
1
 
 receptor/Ca
 
2
 
1
 
 channel
and taken up from the cytosol by the sarcoplasmic/endo-
 
plasmic Ca
 
2
 
1
 
-ATPase (SERCA) (Pozzan et al., 1994). Many
diverse cellular functions are regulated by alterations in
intracellular Ca
 
2
 
1
 
 concentration, including secretion, con-
traction-relaxation, cell motility, cytoplasmic and mito-
chondrial metabolism, protein synthesis and folding, gene
expression, and cell cycle progression (Pozzan et al., 1994).
Evidence now indicates that changes in intracellular Ca
 
2
 
1
 
homeostasis also play a role in modulation of apoptosis
(Oppenheim, 1991; Barres et al., 1992; Preston and Berlin,
1992; Baffy et al., 1993; Lam et al., 1994; Distelhorst et al.,
1996; Marin et al., 1996; McConkey et al., 1996; Reynolds
and Eastman, 1996; Szalai et al., 1999), a naturally occur-
ring form of cell death which is important for proper de-
velopment and homeostasis in many tissues (Jacobson et
al., 1997; Nagata, 1997).
Calreticulin is a major Ca
 
2
 
1
 
-binding chaperone found in
the lumen of the ER (Michalak, 1996; Krause and Micha-
lak, 1997; Meldolesi and Pozzan, 1998; Michalak et al.,
1999). It is also involved in the regulation of intracellular
Ca
 
2
 
1
 
 homeostasis, steroid-sensitive gene expression and
cell adhesion (Krause and Michalak, 1997; Michalak et al.,
1999). Calreticulin shares amino acid sequence identity
with calnexin, an integral ER membrane chaperone (Ber-
geron et al., 1994; Hammond and Helenius, 1995). Cal-
nexin and calreticulin are both chaperones believed to play
a critical role in quality control processes during protein
synthesis and folding (Bergeron et al., 1994; Hammond and
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Helenius, 1995; Helenius et al., 1997; Spiro et al., 1996;
Vassilakos et al., 1998; Ihara et al., 1999; Saito et al., 1999).
Calnexin may also play a role in control of Ca
 
2
 
1
 
 homeosta-
sis (John et al., 1998) Recently, John et al. (1998) reported
that calreticulin and calnexin may interact with SERCA2b
resulting in a lower capacity for Ca
 
2
 
1
 
 transport by the
Ca
 
2
 
1
 
-ATPase.
In this study, we have investigated the possible role of
the ER in modulation of apoptosis. We altered the expres-
sion of calreticulin and calnexin, ER luminal and integral
membrane proteins, and then initiated apoptosis. We
show that increased expression of the ER luminal protein
calreticulin increased cell sensitivity to apoptosis, whereas
overexpression of calnexin, an integral ER membrane pro-
tein, had no significant effect on the drug-induced apopto-
sis. Furthermore, we show that calreticulin-deficient cells,
from calreticulin knockout mice, were significantly resis-
tant to staurosporine-induced apoptosis. This resistance to
apoptosis was accompanied by reduced cytochrome c re-
lease from mitochondria and lower caspase 3 enzyme ac-
tivity. Our findings suggest that the ER, via specific com-
ponents of its luminal environment, may play an important
role in the modulation of cell sensitivity of apoptosis.
 
Materials and Methods
 
Materials
 
[
 
3
 
H]thymidine and 
 
45
 
Ca
 
2
 
1
 
 were from Amersham Pharmacia Biotech. HeLa
Tet-On cells, pTRE and pTK-Hyg plasmids, fetal bovine serum for the
Tet system, doxycycline, hygromycin B, and FITC-labeled Annexin-V
were purchased from CLONTECH Laboratories, Inc. DME, fetal bovine
serum, trypsin-EDTA, 
 
L
 
-glutamine, penicillin, streptomycin, G418 (Ge-
neticin) and RPMI 1640 were purchased from GIBCO BRL. Staurospo-
rine, bradykinin and thapsigargin were from Sigma. Fura-2/AM was from
Molecular Probes. In Situ Cell Death Detection for the TUNEL assay
(TdT-mediated dUTP nick end labeling) was from Boehringer. Restric-
tion endonuclease and DNA-modifying enzymes were obtained from
Boehringer, GIBCO BRL, and Bio/Can Scientific. Goat anti-calreticulin
antibodies were prepared as described previously (Milner et al., 1991).
Rabbit anti-calnexin antibodies were purchased from StressGen. FITC-
conjugated secondary antibodies were from Bio/Can Scientific. Anti-cyto-
chrome c antibody (7H8.2C12) was from PharMingen. Ac-DEVD-AFC
was from Biomol. All chemicals were of the highest grade available.
 
Plasmids
 
cDNA encoding full-length rabbit calreticulin and canine calnexin was
subcloned into the pTRE plasmid to generate pTRE-CRT and pTRE-
CNX expression vectors, respectively. These vectors were used for gener-
ation of the Tet-On–inducible cell lines. The nucleotide sequence of all
cDNAs was confirmed by the DNA Sequencing Laboratory in the De-
partment of Biochemistry, using an Applied Biosystems DNA sequencer
(model 373A). Plasmid DNA was purified by QIAGEN column chroma-
tography.
 
Plasmids and Generation of the Tet-On Calreticulin and 
Calnexin Cell Lines
 
The Ca
 
2
 
1
 
-phosphate method was used for transfection of the HeLa Tet-
On cells, using 40 
 
m
 
g plasmid DNA (pTRE-CRT or pTRE-CNX) and 2
 
m
 
g selection plasmid (pTK-Hyg). Transfected cells were selected for
growth in the presence of 200 
 
m
 
g hygromycin B/ml culture medium. Single
colonies of the hygromycin B–resistant cells were tested for doxycycline
(Dox)-dependent expression of calreticulin and calnexin, by Western blot-
ting with anti-calreticulin or anti-calnexin antibodies. Two cell lines, which
showed highly inducible expression of calreticulin or calnexin, were se-
lected for this study. These cell lines were designated KN1 for inducible
expression of calreticulin, and KNX2 for inducible expression of calnexin.
 
Cell Culture
 
A1.1 cells (cloned cell line derived from mouse T cells) were grown in
RPMI medium supplemented with 5% fetal calf serum, 100 
 
m
 
M 2-mercap-
toethanol, 2 mM 
 
L
 
-glutamine, 10 mM Hepes, pH 7.5, and 50 U penicillin,
50 
 
m
 
g streptomycin, and 5 
 
m
 
g gentamycin per milliliter. A1.1 cells (5 
 
3
 
10
 
6
 
) were incubated in the presence of 5 
 
m
 
M synthetic oligodeoxynucle-
otides in 1 ml RPMI medium per well. The following oligodeoxynucle-
otides were used: anti-sense oligodeoxynucleotide 5
 
9
 
-CCG CCC CGG
CCC GCC ATG CTC CTT TCG GTG-3
 
9
 
 including an ATG initiation
codon (underlined), and scrambled oligodeoxynucleotide 5
 
9
 
-GAC ACG
AAC GAC CAG CGA GGA G-3
 
9
 
. Synthetic oligodeoxynucleotides and
sequencing primers were made in the DNA Sequencing Laboratory in the
Department of Biochemistry, using an Applied Biosystems 394 DNA/
RNA synthesizer. To initiate glucocorticoid-dependent apoptosis, cells
were incubated for 12 h in RPMI containing 5% charcoal-treated fetal calf
serum, followed by incubation for 24 h in RPMI containing 25–500 nM
dexamethasone (Dex) or RPMI alone.
HeLa cells and Tet-On cells were maintained in DME supplemented
with 10% fetal bovine serum, 100 U penicillin/ml, 100 
 
m
 
g DME strepto-
mycin/ml, and 2 mM 
 
L
 
-glutamine. DME was also supplemented with 10%
tetracycline-negative fetal bovine serum for Tet system. 2 
 
m
 
g Dox/ml was
added into the culture medium to induce expression of calreticulin or cal-
nexin in Tet-On cell lines.
Mouse embryonic fibroblasts (MEF) were isolated from calreticulin-
deficient 
 
crt
 
2
 
/
 
2
 
 and wild-type embryos. 
 
crt
 
2
 
/
 
2
 
 and wild-type embryos were
dissociated, washed, trypsinized for 30 min, and cultured in 6-well tissue-
culture plates. To generate immortal MEF cell lines, cells were transfected
with a pSV-7 vector encoding the SV-40 large T antigen (Conzen and
Cole, 1995). After 2 wk in culture individual colonies of immortalized
MEF were picked and used for experiments. Cells were maintained in
DME containing 20% fetal calf serum. To induce apoptosis, cells were in-
cubated with 2 
 
m
 
M, 100 nM, or 10 nM staurosporine for 90 min. This treat-
ment was followed with Annexin-V binding assay, which was carried out
as recommended by the manufacturer and always including propidium
staining assay.
 
Immunoblotting and Immunocytochemistry
 
Cells were washed three times with ice-cold PBS and then lysed as de-
scribed by (Mery et al., 1996). Proteins were separated by SDS-PAGE
(Laemmli, 1970) and transferred to nitrocellulose membrane (Towbin et
al., 1979). Goat anti-calreticulin and rabbit anti-calreticulin (affinity-puri-
fied CRT283) were prepared as described earlier (Milner et al., 1991;
Michalak et al., 1996). Rabbit anti-ERp57 antibodies, a generous gift of D.
Thomas (Genetics Group, Biotechnology Research Institute, National
Research Council of Canada, Montrèal, Canada), were used at 1:1,000
(Zapun et al., 1998). Immunoblotting was carried out as described by (Na-
kamura et al., 1995). For analysis of cytochrome c release from mitochon-
dria, preparation of extracts and immunoblotting was carried out as de-
scribed by (Bossy-Wetzel et al., 1998; Bossy-Wetzel and Green, 1999).
Indirect immunofluorescence of KN1 and KNX2 cells was carried out as
described by (Opas et al., 1991). In brief, KN1 and KNX2 cells were
plated on coverslips and cultured in the presence or absence of 2 
 
m
 
g Dox/
ml for 24 h. Cells were washed with PBS and fixed with 4% paraformalde-
hyde. Coverslips were mounted in Vinol 205S and examined with a Bio-
Rad Laboratories confocal fluorescence microscope (model MRC-600)
equipped with a krypton/argon laser.
 
Apoptosis Assay
 
For the Annexin-V binding assay, cells were plated on 6-cm dishes at 5 
 
3
 
10
 
3
 
/cm
 
2
 
 and incubated for 24 h in the presence or absence of 2 
 
m
 
g Dox/ml.
To induce apoptosis, KN1 and KNX2 cells were incubated for 90 min in
the presence of 2 
 
m
 
M staurosporine or for 24 h in the presence of 200 nM
thapsigargin. Calreticulin-deficient and wild-type MEF were incubated
with 2 
 
m
 
M staurosporine for 4 h. The cells were washed with PBS, har-
vested, and incubated with FITC-labeled Annexin-V as recommended by
the manufacturer, and analyzed by flow cytometry. For the TUNEL assay,
cells were plated on 10-cm dishes at 5 
 
3
 
 10
 
3
 
/cm
 
2
 
 and incubated for 24 h
with or without 2 
 
m
 
g Dox/ml. Staurosporine (10 nM, 100 nM, or 2 
 
m
 
M)
was added for 4 h, or 4 h 30 min, to induce apoptosis. Alternatively, some
cells were treated with UV for 1 min or with 10 or 100 
 
m
 
M etoposide to in- 
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duce apoptosis. The cells were washed with PBS, harvested and incubated
with the TUNEL reaction mixture, as recommended by the manufacturer.
This was followed by flow cytometry or fluorescence microscopy. Caspase
3 activity was measured by the DEVD-AFC cleavage assay (Bossy-Wetzel
and Green, 1999). 50 
 
m
 
g protein extract was diluted in a buffer containing
200 
 
m
 
M Ac-DEVD-AFC, 20 mM Pipes, pH 7.2, 100 mM NaCl, 1 mM
EDTA, 0.1% Chaps, 10% sucrose, and 10 mM DTT (caspase buffer). The
kinetics of substrate cleavage were measured at 37
 
8
 
C under constant agi-
tation using a spectrofluorometer at 
 
l
 
ex
 
 5 
 
400 nm and 
 
l
 
em
 
 at 505 nm. Ap-
optosis was also quantified by staining cells with eosin and hematoxylin
(Bossy-Wetzel et al., 1998). Apoptotic cells were counted using a light mi-
croscope. Apoptosis was detected by cell shrinkage, chromatin condensa-
tion and nuclear fragmentation.
 
Ca
 
2
 
1
 
 Measurements
 
In KN1 cells, the total Ca
 
2
 
1
 
 in ER Ca
 
2
 
1
 
 stores was estimated using 
 
45
 
Ca
 
2
 
1
 
(10 
 
m
 
Ci/ml) as described earlier (Mery et al., 1996). For measurement of
cytoplasmic Ca
 
2
 
1
 
concentration ([Ca
 
2
 
1
 
]
 
c
 
), cells (1.5 
 
3
 
 10
 
6
 
/ml) were loaded
with the fluorescent Ca
 
2
 
1
 
 indicator fura-2/AM (2 
 
m
 
M) taking precautions
to avoid dye sequestration as described by (Mery et al., 1996). Fura-2 fluo-
rescence was measured at 
 
l
 
ex
 
 5 
 
340 nm. To measure changes in cytoplas-
mic Ca
 
2
 
1
 
concentration, cells were stimulated with 1 
 
m
 
M thapsigargin or
with 200 nM bradykinin (Mery et al., 1996; Waser et al., 1997).
 
Miscellaneous
 
Protein assays were carried out as described by (Bradford, 1976). All re-
combinant DNA techniques were conducted according to standard proto-
cols. Transgenic mice expressing the GFP reporter gene under control of
the calreticulin promoter were generated as described (Mesaeli et al.,
1999). Mouse embryos were dissected, fixed and prepared for fluores-
cence microscopy (Mesaeli et al., 1999). Images were reconstructed using
the Adobe Photoshop program.
 
Results
 
Apoptosis is an active and genetically controlled process
of eliminating unwanted cells during development, tissue
turnover and metamorphosis (Jacobson et al., 1997).
While studying transactivation of the calreticulin pro-
moter and expression of the protein during mouse em-
bryogenesis we noticed that the calreticulin promoter
was highly active in several tissues including cells
destined for apoptosis during mouse development. We
monitored transactivation of the calreticulin promoter by
detection of the fluorescent signal obtained from calretic-
ulin promoter-driven expression of the green fluores-
cent protein (GFP) reporter gene in transgenic mice
(Mesaeli et al., 1999). Fig. 1, A and B, shows section of a
developing eye (A) and a limb bud (B) of a 14.5-d-old
transgenic mouse embryo. The highest fluorescent signal,
indicative of high expression of GFP, was found in the
central retina (Fig. 1 A, R), the lens vesicle (Fig. 1 A,
LV) and in the interdigital cells (Fig. 1 B, IC). It is well
established that central retina and lens vesicle cells un-
dergo apoptosis during normal development (Ganan et
al., 1996; Zou and Niswander, 1996). Apoptosis is also re-
sponsible for eliminating the cells between developing
digits (Ganan et al., 1996; Zou and Niswander, 1996).
Furthermore, in preliminary biochemical experiments
with A1.1 cells (a cloned cell line derived from T cells),
we found that when we downregulated calreticulin, using
anti-sense oligodeoxynucleotides (Fig. 2 A), there was a
protective effect against Dex-induced apoptosis as as-
sessed by determining the degree of DNA fragmentation
(Fig. 2 B). Since calreticulin is involved in Ca
 
2
 
1
 
 homeo-
stasis these findings are in line with earlier studies which
 
showed that Ca
 
2
 
1
 
 release from ER may affect Dex-
induced apoptosis in W7MG1 mouse lymphoma cells
(Lam et al., 1993) or T lymphocytes (Jayaraman and
Marks, 1997). Taken together, these findings suggested
to us that changes in expression of calreticulin, an ER lu-
minal protein, may play a role in cell sensitivity to apop-
tosis induced by external stimuli.
Figure 1. Activation of calreticulin promoter in developing eye
and limb buds of transgenic mouse embryos. Transgenic mice ex-
pressing GFP under control of the calreticulin promoter were
generated as described by Mesaeli et al. (1999). Activation of the
calreticulin promoter was monitored by detection of the fluores-
cent signal obtained from calreticulin promoter-driven expres-
sion of the GFP reporter gene (Mesaeli et al., 1999). Mouse em-
bryos (14.5 d old) were dissected out of the uterus and processed
for fluorescence analysis using a confocal microscope (Mesaeli et
al., 1999). (A) A section of a developing embryonic eye; (B) a
section across developing limb bud. High activation of the calre-
ticulin promoter was detected in central retina (R), lens vesicle
(LV) and in interdigital cells (IC). 
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Expression of Calreticulin and Calnexin in
Tet-On–inducible HeLa Cells
 
To investigate the role of calreticulin and calnexin on cell
sensitivity to apoptosis, we generated Tet-On HeLa cell
lines that are inducible with respect to calreticulin (desig-
nated KN1) and calnexin (designated KNX2). In Tet-On
cells, gene expression is turned on when doxycycline
(Dox) is added to the culture medium. Incubation of the
KN1 and KNX2 cells with Dox resulted in 2.3
 
 6 
 
0.2-fold
(mean
 
 6 
 
SD;
 
 n 
 
5 
 
4) and 2.2
 
 6 
 
0.2-fold (mean
 
 6 
 
SD;
 
 n 
 
5 
 
4)
induction in the expression of calreticulin (Fig. 3 A) and
calnexin (Fig. 3 B), respectively. As internal control we
tested for expression of ERp57, an ER luminal chaperone,
in KN1 and KNX2 cells. Fig. 3, A and B, shows that Dox
had no effect on expression of ERp57. Expression of other
ER proteins including BiP, ERp72, protein disulfide
isomerase, Grp94, SERCA2, and InsP
 
3
 
 receptor was also
not affected by Dox (not shown). The doubling time of
these cell lines was 
 
z
 
20 h and was not affected by the ad-
dition of Dox. After induction of protein synthesis with
Dox in KN1 and KNX2 cells calreticulin and calnexin
were both localized to the ER (Fig. 3 C). There was no im-
munoreaction with anti-calreticulin or anti-calnexin anti-
 
bodies in the cytoplasm, in the nucleus, or on the cell sur-
face. This indicates that the Dox-dependent induction of
calreticulin and calnexin resulted in an increased accumu-
lation of these proteins in the ER and not in other intracel-
lular compartments.
 
Induction of Apoptosis in KN1 and KNX2 Cells
 
Staurosporine (Raff et al., 1993; Bertrand et al., 1994; Ja-
cobson et al., 1994) and thapsigargin (Lam et al., 1994)
both induce apoptosis. To investigate the possible involve-
ment of calreticulin and ER in apoptosis, we treated KN1
and KNX2 cells with Dox to induce overexpression of cal-
reticulin and calnexin, respectively. We then incubated the
cells with either thapsigargin or staurosporine, and mea-
sured apoptosis by Annexin-V binding or TUNEL assay.
By itself, Dox did not induce apoptosis in HeLa cells, mock
transfected control cells, or KN1 and KNX2 cells (Figs. 4
and 5, HeLa-On). When thapsigargin was used to induce
apoptosis, we found that cells overexpressing calreticulin
were more sensitive. As shown in Fig. 4, after treatment
with thapsigargin, Annexin-V binding was greater in cells
that were overexpressing calreticulin. Fig. 5 A shows that
after treatment with staurosporine, Annexin-V binding
was also increased in Dox-treated KN1 cells as compared
with untreated KN1 cells. This shows that the cells overex-
pressing calreticulin were more sensitive to staurosporine.
Similar results were obtained with 2 
 
m
 
M and 10 nM stau-
rosporine (data not shown). In contrast, in KNX2 cells
overexpressing calnexin, a small and statistically insignifi-
cant reduction in sensitivity to both thapsigargin (Fig. 4)
and staurosporine (Fig. 5 A) was observed. These results
indicate that the overexpression of calnexin did not affect
apoptosis.
The sensitivity of KN1 and KNX2 cells to staurosporine
was also evaluated by TUNEL analysis (Fig. 5 B). In keep-
ing with the Annexin-V binding results described above,
we found that Dox-dependent overexpression of calreticu-
lin increased the sensitivity of KN1 cells to apoptosis (Fig.
5 B). After incubation with staurosporine, 
 
.
 
30% of
cells overexpressing calreticulin (Dox-treated KN1) were
TUNEL positive, compared with only 18% of control cells.
In contrast, Dox-dependent overexpression of calnexin
did not affect the sensitivity of KNX2 cells to apoptosis.
After treatment with staurosporine, the proportion of cells
that were TUNEL positive was the same in Dox-treated
and control cells.
We also carried out a time course analysis of staurospo-
rine-induced apoptosis in KN1 cells overexpressing cal-
reticulin (Fig. 5, C and D). Increased sensitivity of KN1
cells overexpressing calreticulin to staurosporine-induced
apoptosis was observed after 0–4 h of incubation with the
drug (Fig. 5, C and D). Time course for both Annexin-V
binding (Fig. 5 C) and the appearance of TUNEL-positive
cells (Fig. 5 D) were comparable indicating that overex-
pression of calreticulin likely affected the rate of apoptosis
rather than the sequence of events associated with apop-
tosis.
Our results show that KN1 cells are more sensitive to
apoptosis when they are overexpressing calreticulin. To
determine whether or not apoptosis was occurring via sim-
ilar pathways in control and test cells, we measured cyto-
Figure 2. Calreticulin modulates dexamethasone-dependent ap-
optosis of A1.1 cells. (A) Western blot analysis of calreticulin in
A1.1 cells incubated with calreticulin-specific anti-sense oligode-
oxynucleotide. Cells were lysed with RIPA buffer, protein sepa-
rated in SDS-PAGE, transferred to nitrocellulose membrane,
and probed with goat anti-calreticulin antibodies. Lanes 1–3, 10,
20, and 30 mg of cell extract from anti-sense oligodeoxynucle-
otide-treated A1.1 cells, respectively; lanes 4–6, 10, 20, and 30 mg
of cell extract from untreated A1.1 cells, respectively. CRT, cal-
reticulin. (B) Downregulation of expression of calreticulin was
regulated in A1.1 cells by incubation with specific anti-sense oli-
godeoxynucleotide followed by DNA fragmentation analysis.
Apoptosis was induced with a different concentration of Dex.
Open bar, control cells; hatched bar, cells treated with scrambled
control oligodeoxynucleotide; full bar, cells treated with anti-
sense oligodeoxynucleotide. Data are means 6 SD of three inde-
pendent experiments. 
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chrome c release from the mitochondria. Overexpression
of calreticulin was induced with Dox, and then apoptosis
was induced by treatment with staurosporine or etoposide.
We prepared cell extracts, which were devoid of mito-
chondria, and then we assessed cytochrome c levels by im-
munoblotting. In KN1 cells treated with staurosporine or
etoposide there was a detectable release of cytochrome c
from the mitochondria (Fig. 5 E). In untreated KN1 cells
there was no release of cytochrome c from the mitochon-
dria (Fig. 5 E). In KN1 cells first incubated with Dox
Figure 3. Expression of calreticulin
and calnexin in Tet-On–inducible
HeLa cell lines. Overexpression of
calreticulin (A, KN1 cells) or cal-
nexin (B, KNX2 cells) was induced
by incubation of the cells in the
presence of 2 mM Dox for 24 h.
Cells were harvested, lysed with
RIPA buffer. 10 mg of protein was
separated in SDS-PAGE trans-
ferred to nitrocellulose membrane
and probed with anti-calreticulin
(A) or anti-calnexin (B) antibodies.
Blots were normalized by probing
with anti-ERp57 antibodies. Addi-
tion of Dox to KN1 or KNX2 cells
resulted in 2.3 6 0.2-fold (mean 6
SE; n 5 4) and 2.2 6 0.2-fold
(mean 6 SE; n 5 4) induction in the
expression of calreticulin (A) and
calnexin (B), respectively, as esti-
mated by densitometry. The posi-
tions of molecular markers are
indicated. (C) Localization of cal-
reticulin and calnexin in KN1
(calreticulin inducible) and KNX2
(calnexin inducible). (Top) Local-
ization of calreticulin and calnexin
in the calnexin Tet-On KNX2 (cal-
nexin inducible). (Bottom) Local-
ization of calreticulin and calnexin
in the calreticulin Tet-On KN1 cells
(calreticulin inducible). To induce
expression of calreticulin and cal-
nexin, KN1 and KNX2 cells were
treated with Dox for 24 h, respec-
tively (1Dox). Both calreticulin
and calnexin localized predomi-
nantly to an ER-like intracellular
network. CRT, calreticulin; CNX,
calnexin.The Journal of Cell Biology, Volume 150, 2000 736
(overexpressing calreticulin) and then treated with stauro-
sporine or etoposide, the release of cytochrome c from the
mitochondria was consistently higher (Fig. 5 E, 1 Dox).
To confirm the differences we had found in Annexin-V
binding, TUNEL assay and cytochrome c release from
mitochondria, we measured rates of DEVD cleavage
(caspase activity) in cytosolic extracts from KN1 cells
overexpressing calreticulin. Calreticulin expression was in-
duced with Dox followed by a 60-min incubation with
staurosporine to induce apoptosis. As expected the DEVD
cleavage (caspase) activity was 1.75-fold higher in calre-
ticulin overexpressing (Dox- and staurosporine-treated)
KN1 cells than in the KN1 cells incubated with staurospo-
rine alone.
Ca21 Homeostasis in KN1 Cells
It is well documented that calreticulin plays a role in the
regulation of intracellular Ca21 homeostasis (Liu et al.,
1994; Bastianutto et al., 1995; Camacho and Lechleiter,
1995; Mery et al., 1996; Coppolino et al., 1997; Fasolato et
al., 1998; John et al., 1998; Mesaeli et al., 1999). Therefore,
we investigated the effect on Ca21 homeostasis of overex-
pressing calreticulin in KN1 cells. First, we used equilib-
rium loading techniques to determine whether the Ca21
content of intracellular Ca21 stores was modified in KN1
cells that were overexpressing calreticulin (Mery et al.,
1996). Control KN1 cells contained 70 6 10 pmol of Ca21/
106 cells (mean 6 SD; n 5 3) whereas the KN1 cells
treated with Dox (overexpressing calreticulin) contained
148 6 12 pmol of Ca21/106 cells (mean 6 SD; n 5 3). Simi-
lar increases in the Ca21 content of intracellular Ca21
stores have been reported for cells transiently (Bas-
tianutto et al., 1995) and stably (Mery et al., 1996) trans-
fected with a calreticulin expression vector.
Second, we used a Ca21-sensitive fluorescent dye, fura-2,
to investigate the effects of overexpressing calreticulin on
[Ca21]c in KN1 cells. Basal cytoplasmic Ca21 concentra-
tion ([Ca21]c) in control and Dox-treated KN1 cells was
similar (z130 6 10 nM; mean 6 SD; n 5 3). To measure
the Ca21 associated with rapidly exchangeable intracellu-
lar Ca21 stores, we used thapsigargin, an inhibitor of
SERCA (Thastrup et al., 1990). When cells were treated
with thapsigargin, the peak and duration of the [Ca21]c el-
evations were comparable in control and Dox-treated
KN1 cells (not shown). In contrast to this, we found that
control and Dox-treated KN1 cells differed in their re-
sponse to bradykinin. Bradykinin causes the release of
Ca21 from internal stores via activation of endogenous,
agonist-dependent pathways. In both control and Dox-
treated KN1 cells, bradykinin caused a rapid and transient
increase in [Ca21]c. However, the amplitude of this [Ca21]c
elevation was z1.5-fold greater in cells overexpressing cal-
reticulin (620 6 25 nM; mean 6 SD; n 5 3) than in control
cells (350 6 20 nM; mean 6 SD; n 5 3). It remains unclear
why increased elevation of [Ca21]c in KN1 cells overex-
pressing calreticulin was observed with bradykinin but not
with thapsigargin. It is possible, that in the case of thapsi-
gargin the slow Ca21 release allows negative feedback
Figure 4. Thapsigargin-depen-
dent induction of apoptosis in
cells overexpressing calreticu-
lin and calnexin. KN1 and
KNX2 cells were incubated
with 2 mg Dox/ml (filled bars)
for 24 h to induce expression
of calreticulin and calnexin,
respectively. Cells were
treated with thapsigargin fol-
lowed by Annexin-V binding
assay. HeLa-On, mock trans-
fected Tet-On HeLa cells. (Open bars) Cells not incubated with
Dox; filled bars, Dox-treated cells. 100% value corresponds to
10,000 cells. Data are means 6 SD of three independent experi-
ments. **P , 0.001.
Figure 5. Induction of apoptosis in cells overexpressing calre-
ticulin and calnexin. KN1 and KNX2 cells were incubated with 2
mg Dox/ml (filled bars) for 24 h to induce expression of calreticu-
lin and calnexin, respectively. Cells were treated with staurospo-
rine (A–D) followed by Annexin-V binding assay (A and C) or
TUNEL analysis (B and E). In C and D KN1 cells were incu-
bated with staurosporine for the time indicated in the figure fol-
lowed by Annexin-V binding assay (C) or TUNEL analysis (D).
Open bars, cells not incubated with Dox; filled bars, Dox-treated
cells. 100% value corresponds to 10,000 cells. Data are means 6
SD of three independent experiments. In E, KN1 cells were incu-
bated with 2 mg Dox/ml (1) for 24 h to induce expression of cal-
reticulin. To induce apoptosis control or Dox-treated cells were
incubated with 100 nM staurosporine (STS) or 100 mM etopo-
side. Cytosolic extracts were prepared devoid of mitochondria,
separated by SDS-PAGE and immunoblotted with anti-cyto-
chrome c antibodies (Bossy-Wetzel and Green, 1999). The posi-
tion of cytochrome c (Cyt. c) is indicated by the arrow. **P ,
0.001 and *P , 0.005.Nakamura et al. Endoplasmic Reticulum and Apoptosis 737
mechanism such as extrusion of Ca21 via the plasma mem-
brane Ca21-ATPase to obscure the differences in Ca21 re-
lease in relation to the level of [Ca21]c measurements
(Mery et al., 1996).
In summary, we show that Dox-dependent overexpres-
sion of calreticulin in KN1 cells results in increased storage
of Ca21 in the ER and in elevated agonist-dependent Ca21
release from internal stores. In contrast, we found no sig-
nificant changes in total intracellular Ca21 or in Ca21 re-
lease in KNX2 cells overexpressing calnexin.
Induction of Apoptosis in Calreticulin-deficient Cells
Recently, we have generated a calreticulin knockout em-
bryo (Mesaeli et al., 1999). For this study we established
an immortalized calreticulin-deficient, MEF cell line (for
details see Materials and Methods). Since crt2/2 cells do
not express calreticulin (Fig. 6 A) they provide an ideal
tool to investigate the effects of calreticulin deficiency on
apoptosis. Fig. 6 B compares staurosporine-induced apop-
tosis in wild-type cells (containing calreticulin) and calre-
ticulin-deficient cells (crt2/2), as measured by Annexin-V
binding. Interestingly, the calreticulin-deficient cells were
significantly resistant to apoptosis (Fig. 6 B). We also per-
formed a kinetic analysis of apoptosis induced by etopo-
side, staurosporine and UV (UVB; Fig. 6 C). Fig. 6 C shows
that calreticulin-deficient cells were consistently more re-
sistant to apoptosis compared with the wild-type cells.
In parallel with these studies, we also tested the effects
of calreticulin deficiency on Ca21 homeostasis, using the
Ca21-sensitive fluorescent dye fura-2. We reported earlier
(Mesaeli et al., 1999) that in wild-type and calreticulin-
deficient MEF resting [Ca21]c was similar (80 6 15 nM;
mean 6 SD; n 5 3). When cells were treated with thapsi-
gargin the peak and duration of the [Ca21]c elevations
were comparable in control and calreticulin-deficient
MEF (not shown; Mesaeli et al., 1999). In contrast, brady-
kinin-dependent Ca21 release from intracellular Ca21
stores was inhibited in calreticulin-deficient MEF (Mesaeli
et al., 1999).
To determine whether apoptosis was occurring by simi-
lar pathways in wild-type and calreticulin-deficient cells,
we measured cytochrome c release from the mitochondria.
Wild-type and calreticulin-deficient MEF were treated
with UV, etoposide or staurosporine, and then cytosolic
extracts, devoid of mitochondria, were prepared and ana-
lyzed by immunoblotting. As expected, in untreated cells
there was no release of cytochrome c from the mitochon-
dria (Fig. 7 A, untreated). Treatment of wild-type MEF
with UV, etoposide or staurosporine resulted in cyto-
chrome c release from the mitochondria (Fig. 7 A, 1/1).
However, cytochrome c release from mitochondria of cal-
reticulin-deficient cells, after treatment with UV, etopo-
side or staurosporine, was reduced (Fig. 7 A, 2/2). Dur-
ing apoptosis, cytochrome c release from mitochondria
activates caspase 9, which then cleaves and activates
procaspase 3 (Srinivasula et al., 1998). To confirm the
differences we had found in cytochrome c release from mi-
tochondria, we measured rates of DEVD cleavage in cyto-
solic extracts, using the fluorometric substrate DEVD-
AFC. We treated wild-type and calreticulin-deficient MEF
with UV, etoposide or staurosporine, and then we pre-
pared cytosolic extracts from the cells. No caspase activity
was detected in untreated cells (Fig. 7 B, untreated). DEVD
cleavage (caspase) activity was high in wild-type MEF
treated with UV or etoposide (Fig. 7 B, wt), but was re-
duced in the calreticulin-deficient cells (Fig. 7 B, crt2/2).
There was no detectable DEVDase activity in the stauro-
sporine-treated crt2/2 (Fig. 7 B). However, there was sig-
nificant release of cytochrome c from mitochondria of crt2/2
treated with staurosporine (Fig. 7 A). This apparent dis-
Figure 6. Induction of apoptosis in calreticulin-deficient cells.
Wild-type (wt) and calreticulin deficient (crt2/2) mouse fibro-
blast cell lines were established as described in Materials and
Methods. (A) Cells were lysed with RIPA buffer, protein sepa-
rated in SDS-PAGE, transferred to nitrocellulose membrane and
probed with the affinity-purified rabbit anti-calreticulin antibody.
The location of calreticulin (CRT) and Bio-Rad Laboratories
molecular mass markers are indicated. (B) Wild-type (wt) and
calreticulin-deficient (crt2/2) mouse embryonic fibroblasts were
treated for 30 min in the absence (open bars) or presence (filled
bars) of staurosporine (STS) followed by Annexin-V binding as-
say as described under Materials and Methods. 100% value cor-
responds to 10,000 cells. Data are means 6 SD of two indepen-
dent experiments. In C, wild-type (wt) and calreticulin deficient
(crt2/2) mouse embryonic fibroblasts were treated with 10 mM
etoposide, 10 nM staurosporine (STS), or UV for 1 min. The per-
centage of apoptosis was determined by light microscopy of eosin
and hematoxylin-stained cells as described in Materials and
Methods. Statistically significant: *P , 0.001.The Journal of Cell Biology, Volume 150, 2000 738
crepancy is not surprising since mitochondrial cytochrome
c release does not always depend on caspase activity in
many apoptotic systems (Xiang et al., 1996; Yucheng et al.,
2000).
Discussion
In this study, we found that overexpression of calreticulin
increased cell sensitivity to both thapsigargin-induced ap-
optosis and staurosporine-induced apoptosis. However, the
overexpression of calnexin, another Ca21-binding chaper-
one of the ER, had no significant effect on drug-induced
apoptosis. Conversely, we found that cells lacking cal-
reticulin were considerably resistant to drug-induced ap-
optosis. When we investigated Ca21 homeostasis in cells
overexpressing calreticulin, we found that bradykinin-
dependent elevation of [Ca21]c was increased. In contrast,
in calreticulin-deficient cells bradykinin-dependent eleva-
tion of [Ca21]c was inhibited (Mesaeli et al., 1999). We
conclude that ER luminal environment in general and cal-
reticulin in particular play a significant role in determining
cell sensitivity to drug-induced apoptosis. This is likely due
to calreticulin function as a regulator of Ca21 homeostasis.
Most importantly, we show that changes in the expression
of calreticulin, which is resident in the lumen of the ER,
affect the mitochondrial cytochrome c release/caspase sig-
naling pathway of apoptosis.
Calreticulin is a ubiquitous Ca21 binding protein, which
is located in the ER and which has been implicated in such
diverse functions as regulation of intracellular Ca21 ho-
meostasis, chaperone activity, gene expression and cell ad-
hesion (Michalak et al., 1999). Given the diversity of its ac-
tivities, there are many routes via which calreticulin might
affect cell sensitivity to drug-induced apoptosis. In this
study, we have shown that the lectin-like activity of calre-
ticulin is probably not involved. The ER proteins calre-
ticulin and calnexin share many chaperone functions; both
are lectin-like chaperones which preferentially bind mono-
glucosylated oligosaccharides (Bergeron et al., 1994; Spiro
et al., 1996; Helenius et al., 1997; Vassilakos et al., 1998)
and misfolded proteins (Ihara et al., 1999; Saito et al.,
1999). We found that altered expression of calnexin had
no significant effect on cell sensitivity to apoptosis. It is,
therefore, unlikely that calreticulin’s chaperone activity
shared with calnexin is involved in the observed changes in
cell sensitivity to apoptosis. However, it cannot be ruled
out that calreticulin chaperone activity towards a calre-
ticulin-specific substrate may also play a role in modula-
tion of cell sensitivity to apoptosis.
Calreticulin is a Ca21 binding protein that modulates in-
tracellular Ca21 homeostasis (Liu et al., 1994; Bastianutto
et al., 1995; Camacho and Lechleiter, 1995; Mery et al.,
1996; Coppolino et al., 1997; Fasolato et al., 1998; John et
al., 1998; Mesaeli et al., 1999) and Ca21 plays an important
role in apoptosis (Preston and Berlin, 1992; Baffy et al.,
1993; Lam et al., 1994; Distelhorst et al., 1996; Marin et
al., 1996; McConkey et al., 1996; Reynolds and Eastman,
1996). Differential expression of calreticulin affects Ca21
storage capacity of the ER, and most importantly, it mod-
ulates Ca21 release from the ER (Liu et al., 1994; Bas-
tianutto et al., 1995; Camacho and Lechleiter, 1995; Mery
et al., 1996; Coppolino et al., 1997; Fasolato et al., 1998;
John et al., 1998; Mesaeli et al., 1999). For example we
found that overexpression of calreticulin in the Tet-On–induc-
ible system led to increased Ca21 storage in the ER, and to
increased elevation of [Ca21]c in response to bradykinin.
Furthermore, we have previously found that calreticulin-
deficient MEF do not have a measurable InsP3-dependent
Ca21 release when stimulated with bradykinin (Mesaeli et
al., 1999), indicating that calreticulin plays a role in modu-
lating InsP3 receptor pathway. Camacho’s group has pro-
posed that calreticulin may modulate the function of the
InsP3 receptor and/or SERCA (Camacho and Lechleiter,
1995). Recently, John et al. (1998) reported that calreticu-
lin may interact with SERCA2b, resulting in a lower trans-
port capacity for the Ca21-ATPase. We have shown that
changes in Ca21 homeostasis, particularly agonist-depen-
dent Ca21 release from the ER of calreticulin-deficient
cells, correlate well with changes in cell sensitivity to stau-
rosporine-induced apoptosis.
One most important implication of this current work is
that changes in the lumen of the ER modify the mitochon-
drial cytochrome c/caspase apoptosis signaling pathway.
For example, we found that, when cells are induced to un-
dergo apoptosis, cytochrome c release from mitochondria
and cytosolic caspase activity are both lower in calreticu-
lin-deficient cells than in wild-type cells. Rizzuto et al.
(1998) have shown that there are numerous close contacts
between the ER and mitochondria, and that opening of
the InsP3/Ca21 channel in the ER affects Ca21 homeosta-
sis in mitochondria. Close proximity between ER and
mitochondria may play a role in the regulation of Ca21
signaling (Rizzuto et al., 1998) and cell sensitivity to apop-
tosis.
There is a growing body of evidence that the ER may
play an important role in the apoptotic signaling processes,
which lead to downstream activation of caspases and other
proteases. For example, under normal conditions, Bcl-2
and Bcl-XL colocalize to the mitochondria and ER (Zhu et
Figure 7. DEVD cleavage
activity and cytochrome c re-
lease from mitochondria in
calreticulin-deficient cells. In
A, wild-type (1/1) and
calreticulin-deficient (2/2)
MEF were treated with UVB
for 1 min, 10 mM etoposide,
or 10 nM staurosporine
(STS). 8 h after the treatment
cytosolic extracts were pre-
pared devoid of mitochon-
dria, separated by SDS-
PAGE, and immunoblotted
with anti-cytochrome c anti-
bodies (Bossy-Wetzel and
Green, 1999). The position of
cytochrome c (Cyt. c) is in-
dicated by the arrow. In B,
cytosolic extracts from wild-
type (wt) and calreticulin-
deficient (crt2/2) MEF treated with UVB for 1 min, 10 mM eto-
poside, or 10 nM staurosporine (STS) were prepared and tested
for DEVD-specific cleavage activity as described in Materials
and Methods.Nakamura et al. Endoplasmic Reticulum and Apoptosis 739
al., 1996; Ng et al., 1997; Ng and Shore, 1998). Procaspase
8 and Bap31, a newly identified component in apoptotic
signaling, are also localized to the ER (Ng et al., 1997; Ng
and Shore, 1998) indicating that Bap31 could influence
Bcl-2, Bcl-XL and procaspase 8 (Ng et al., 1997). Bcl-2 pro-
tects cells from apoptosis and it is localized to ER and
outer mitochondrial membrane (Lithgow et al., 1994; Zhu
et al., 1996) suggesting that the protein may affect apopto-
sis by interfering with a specific function of the ER. In-
deed, overexpression of Bcl-2 in either HeLa cells or
mouse lymphoma A20 cells protects from apoptosis and
results in reduced agonist-stimulated Ca21 release from
the thapsigargin-sensitive (ER) Ca21 stores (Pinton et al.,
2000; Foyouzi-Youseffi et al., 2000). In this study, we show
that calreticulin-deficient cells are also resistant to apopto-
sis and, similarly to Bcl-2 overexpressers (Pinton et al.,
2000), they have reduced agonist-stimulated Ca21 release
(Mesaeli et al., 1999). However, there is no change in the
level of Bcl-2 in neither calreticulin deficient cells nor in
cells overexpressing the protein (data not shown). There-
fore, changes in cell sensitivity to apoptosis reported here
are likely due to the modulation of expression of calreticu-
lin and its effect on Ca21 homeostasis. Furthermore, ER-
associated InsP3 receptor/Ca21 channel was recently iden-
tified as a new target for caspase 3 (Hirota et al., 1999).
InsP3 receptor-mediated cytosolic Ca21 spikes may also af-
fect mitochondrial permeability during an apoptotic event
(Szalai et al., 1999). Calreticulin expression is upregulated
under these ER stress conditions (Llewellyn et al., 1996;
Nguyen et al., 1996; Waser et al., 1997). It is not surprising,
therefore, that changes in the ER luminal environment,
described in this study, have profound effects on cell sensi-
tivity to apoptosis. Our work suggests that calreticulin, and
perhaps other proteins resident in the lumen of the ER,
contributes to the regulation of cell sensitivity to apopto-
sis. Therefore, changes in ER-dependent Ca21 homeosta-
sis, and changes in expression of Ca21 binding proteins in
the ER, may confer sensitivity to apoptosis caused by di-
verse stimuli. Yuan’s group have recently reported that
caspase-12 is localized to the ER membrane and it is acti-
vated specifically by ER stress including disruption of
Ca21 homeostasis by thapsigargin or ionophore A23187
(Nakagawa et al., 2000). Therefore, it is also possible that
stress in the ER due to, for example, differential expres-
sion of calreticulin can result in activation of apoptotic
pathway(s) independent of mitochondria (Nakagawa et
al., 2000).
Apoptosis plays an essential role during development
(Jacobson et al., 1997). In many organs, cells are overpro-
duced and then reduced by apoptosis to adjust their num-
ber. In vertebrate nervous system, for example, both neu-
rons and oligodendrocytes are generated in excess, and up
to half or more are eliminated by apoptosis (Oppenheim,
1991; Barres et al., 1992). During the formation of embry-
onic eye many of central retina and lens vesicle cells are
also eliminated by apoptosis (Ganan et al., 1996; Zou and
Niswander, 1996). The developing limb is a classical model
where apoptosis has been acknowledged as a fundamental
morphological mechanism responsible for the elimination
of the cells between developing digits (Ganan et al., 1996;
Zou and Niswander, 1996). In this respect, as shown in Fig.
1, the calreticulin gene is highly activated in mouse em-
bryo interdigital cells, in the central retina and in lens vesi-
cle suggesting that changes in the expression of calreticu-
lin, an ER luminal protein, may play a role in apoptosis
during embryogenesis. Future studies are required to ex-
tend these preliminary observations and established corre-
lation between calreticulin expression and periods of ap-
optosis during embryogenesis. An important point is that
calreticulin is not a signal to initiate apoptosis, instead
overexpression of the protein and/or changes in the ER
luminal environment may alter cell sensitivity to a drug-
induced apoptosis. This suggests that apoptosis may de-
pend on both the presence of external apoptosis-activating
signals, and, as shown in this study, on an internal factor
represented by the ER. Alteration in the organization of
ER and ER luminal environment are not initiators of ap-
optosis but they may be responsible for the modulation of
cell susceptibility to apoptosis induced by the external
stimuli.
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